Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus : Current Opinion in Rheumatology

Secondary Logo

Journal Logo

IMMUNOPATHOGENESIS AND TREATMENT OF AUTOIMMUNE DISEASES: Edited by George C. Tsokos

Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus

Akbarzadeh, Reza; Riemekasten, Gabriela; Humrich, Jens Y.

Author Information
Current Opinion in Rheumatology 35(2):p 98-106, March 2023. | DOI: 10.1097/BOR.0000000000000924

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid